Serpin Pharma

Developing New Therapeutics for Autoimmune, Inflammatory and Infectious Diseases.

Launch date

2011

Employees

Manassas Virginia (HQ)

Date	Investors	Amount	Round
Jan 2013	US Department of Health and Human Services	$330k	Grant
Sep 2016	National Institutes of Health Commonwealth of Virginia	$950k	Grant
Jan 2017	Virginia Catalyst	$2.0m	Grant
Jun 2017	Virginia Catalyst	$400k	Grant
Total Funding		€3.3m

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about Serpin Pharma